Back to all bills
HR 2592119th CongressIntroduced
Aviation Medication Transparency Act of 2025
Introduced: Oct 18, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Aviation Medication Transparency Act requires the FAA to publish and maintain a publicly available list of medications approved for use by airmen, including information about restrictions and 'Do Not Issue' medications.
Key Points
- 1Requires FAA to publish medication list within one year of enactment
- 2Mandates consultation with aeromedical working groups and pilot/air traffic controller representatives
- 3Includes information about duty restrictions for medication stabilization
- 4Lists both approved medications and 'Do Not Issue' medications
- 5Requires annual updates to the medication list
- 6Provides mechanism for medical providers to contact FAA with questions
Impact Areas
Aviation medical certification processPilot and air traffic controller healthAviation safetyMedical provider communityFederal Aviation Administration operations
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025